340B Ceiling Price, Civil Monetary Penalties Rule Delayed Until March 21

The Health Resources and Services Administration delayed implementation of the 340B ceiling price and manufacturer civil monetary penalties rule until March 21, in line with the regulatory freeze President Donald Trump implemented shortly after taking office. The regulation was originally set to go into effect on March 6. The rule deals with setting prices under the 340B drug discount program. It finalized the so-called “penny-pricing policy” that drug makers oppose and laid out a formula for drug manufacturers to...